|

Escitalopram Clinical Trials

10 actively recruiting trials across 2 locations

Also known as: ATC code: N06AB10, Active Comparator, Cipralex, Lexapro

Other6 trials

Development and Application of Comprehensive Intervention Techniques for Adolescent Depression
N/A
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
Phase 2
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Phase 3
Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole
N/A
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Phase 4
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Phase 3

Cincinnati, Ohio3 trials

Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)

University of Cincinnati

Phase 4
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)

University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience

Phase 4
Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)

University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience

Phase 4

Dallas, Texas1 trial

Escitalopram in Asthma Patients With Frequent Exacerbation

UT Southwestern, 1440 Empire Central, Ste. LD4.100

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.